Changes in plasma HDL-cholesterol in women using oral contraceptives in Kenya

dc.contributor.author	Maina Francis W.
dc.contributor.author	Sekadde-Kigondu C B.
dc.contributor.author	Ojwang PJ.
dc.contributor.author	Mati JK.
dc.date.accessioned	2013-06-06T14:14:14Z
dc.date.available	2013-06-06T14:14:14Z
dc.date.issued	1987-07
dc.identifier.citation	East Afr Med J. 1987 Jul;64(7):442-7.	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/3691360
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/29435
dc.description.abstract	125 black Kenyan women attending the Kenyatta National Family Welfare Clinic were randomly allocated to combined and fixed dose oral contraceptives (Eugynon: 500 mcg dl-norgestrel + 50 mcg ethinyl estradiol or Microgynon: 150 mcg levonorgestel + 30 mcg ethinyl estradiol). They were between 18-33 years of age with a mean of 25 +or- 7 years. The mean parity of this group was 3 and they had a mean education standard of 8 years. Fasting blood sampled were taken on recruitment (control cycle) and thereafter once for cycles 1, 3, 6, 9, and 12 during OC use. HDL-cholesterol was estimated in the sear. The 2 OCs elicited a significant decrease in levels of HDL-cholesterol (p0.01).	en
dc.language.iso	en	en
dc.title	Changes in plasma HDL-cholesterol in women using oral contraceptives in Kenya	en
dc.type	Article	en